Variable | Recurrence-Free Survival | Overall survival | ||||||
---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
HR (95%CI) | P | HR (95%CI) | HR (95%CI) | P | HR (95%CI) | P | ||
Age | 5.649 (0.743 ± 42.966) | 0.094 | 2.407 (0.287 ± 20.206) | 0.592 | 5.249 (0.687 ± 40.135) | 0.110 | ||
Stage | 2.246 (1.814 ± 6.196) | 0.118 | 2.625 (0.920 ± 7.486) | 0.071 | 1.763 (0.585 ± 5.310) | 0.314 | ||
Tumor size | 2.001 (0.726 ± 5.519) | 0.180 | 2.344 (0.822 ± 6.684) | 0.111 | ||||
Lymphovascular invasion | 3.250 (0.917 ± 11.519) | 0.068 | 0.324 (0.064 ± 1.631) | 0.171 | 4.802 (1.074 ± 21.458) | 0.040 | 0.414 (0.080 ± 2.141) | 0.293 |
Stromal invasion depth | 0.263 (0.059 ± 1.168) | 0.079 | 0.724 (0.150 ± 3.503) | 0.689 | 0.272 (0.061 ± 1.217) | 0.089 | 0.885 (0.168 ± 4.667) | 0.885 |
Lymph node metastasis | 11.448 (3.223 ± 40.664) | 0.000 | 7.695 (1.562 ± 37.900) | 0.012 | 10.273 (2860 ± 36.893) | 0.000 | 7.156 (1.415 ± 36.176) | 0.017 |
Parametrial invasion | 2.165 (0.488 ± 9.595) | 0.309 | 2.433 (0.544 ± 10.872) | 0.245 | ||||
Margin | 1.773 (0.233 ± 13.492) | 0.580 | 1.892 (0.247 ± 14.469) | 0.539 | ||||
Serum EV-Wnt 7b | 16.554 (2.176 ± 125.962) | 0.007 | 11.579 (1.297 ± 103.400) | 0.028 | 15.159 (1.982 ± 115.93) | 0.009 | 11.450 (1.289 ± 101.735) | 0.029 |